These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1970195)

  • 1. Unusual topogenic sequence directs prion protein biogenesis.
    Lopez CD; Yost CS; Prusiner SB; Myers RM; Lingappa VR
    Science; 1990 Apr; 248(4952):226-9. PubMed ID: 1970195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein.
    Yost CS; Lopez CD; Prusiner SB; Myers RM; Lingappa VR
    Nature; 1990 Feb; 343(6259):669-72. PubMed ID: 1968226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a secretory form of the cellular prion protein.
    Hay B; Prusiner SB; Lingappa VR
    Biochemistry; 1987 Dec; 26(25):8110-5. PubMed ID: 3126796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of carboxyl-terminal domain translocation during prion protein biogenesis.
    De Fea KA; Nakahara DH; Calayag MC; Yost CS; Mirels LF; Prusiner SB; Lingappa VR
    J Biol Chem; 1994 Jun; 269(24):16810-20. PubMed ID: 7911469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biology and transgenetics of prion diseases.
    Prusiner SB
    Crit Rev Biochem Mol Biol; 1991; 26(5-6):397-438. PubMed ID: 1684745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells.
    Rogers M; Yehiely F; Scott M; Prusiner SB
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3182-6. PubMed ID: 8475059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of prion proteins with monospecific antisera to synthetic peptides.
    Barry RA; Vincent MT; Kent SB; Hood LE; Prusiner SB
    J Immunol; 1988 Feb; 140(4):1188-93. PubMed ID: 3125249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoaffinity purification and neutralization of scrapie prions.
    Gabizon R; McKinley MP; Groth D; Westaway D; DeArmond SJ; Carlson GA; Prusiner SB
    Prog Clin Biol Res; 1989; 317():583-600. PubMed ID: 2574871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation.
    Taraboulos A; Rogers M; Borchelt DR; McKinley MP; Scott M; Serban D; Prusiner SB
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8262-6. PubMed ID: 1978322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular accumulation of the cellular prion protein after mutagenesis of its Asn-linked glycosylation sites.
    Rogers M; Taraboulos A; Scott M; Groth D; Prusiner SB
    Glycobiology; 1990 Sep; 1(1):101-9. PubMed ID: 1983782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmissible and genetic prion diseases share a common pathway of neurodegeneration.
    Hegde RS; Tremblay P; Groth D; DeArmond SJ; Prusiner SB; Lingappa VR
    Nature; 1999 Dec; 402(6763):822-6. PubMed ID: 10617204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic structure of the human prion protein gene.
    Puckett C; Concannon P; Casey C; Hood L
    Am J Hum Genet; 1991 Aug; 49(2):320-9. PubMed ID: 1678248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric prion protein expression in cultured cells and transgenic mice.
    Scott MR; Köhler R; Foster D; Prusiner SB
    Protein Sci; 1992 Aug; 1(8):986-97. PubMed ID: 1338978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells.
    Borchelt DR; Scott M; Taraboulos A; Stahl N; Prusiner SB
    J Cell Biol; 1990 Mar; 110(3):743-52. PubMed ID: 1968466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
    Prusiner SB
    Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion strain-dependent differences in conversion of mutant prion proteins in cell culture.
    Atarashi R; Sim VL; Nishida N; Caughey B; Katamine S
    J Virol; 2006 Aug; 80(16):7854-62. PubMed ID: 16873242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient initiation of mammalian mRNA translation at a CUG codon.
    Dasso MC; Jackson RJ
    Nucleic Acids Res; 1989 Aug; 17(16):6485-97. PubMed ID: 2780285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polo-like kinase 3 (PLK3) mediates the clearance of the accumulated PrP mutants transiently expressed in cultured cells and pathogenic PrP(Sc) in prion infected cell line via protein interaction.
    Wang H; Tian C; Fan XY; Chen LN; Lv Y; Sun J; Zhao YJ; Zhang LB; Wang J; Shi Q; Gao C; Chen C; Shao QX; Dong XP
    Int J Biochem Cell Biol; 2015 May; 62():24-35. PubMed ID: 25724737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of topogenic sequences in the movement of proteins through membranes.
    Robinson A; Austen B
    Biochem J; 1987 Sep; 246(2):249-61. PubMed ID: 3318806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.